REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH)

CUSIP: 76152G100

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class
Equity / Common Stock, $0.0001 par value per share
Total 13F shares
6,849,687
Total 13F value
$8,748,871
Holder snapshot 6 visible 7 signals
Share change
+1,278,893
Put/Call ratio
30%
SEC-reported price per share
$1.28
Number of holders
30
Value change
+$1,342,404
Number of buys
20
Open additional details 1 more signal available
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
13,730,837

Security key

76152G100

Report period

Q2 2024

Institutions

30

Top holders

10

RVPH full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings REVIVA PHARMACEUTICALS HOLDINGS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Woodline Partners LP
Disclosed value leader
Woodline Partners LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 7.7% Showing 1-6 of 15 holder rows.

Quick read

Woodline Partners LP leads the comparable SEC ownership view at 7.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Woodline Partners LP's linked filing trail.
Comparable ownership Top 5
Woodline Partners LP 7.7%
VANGUARD GROUP INC 7.3%
MILLENNIUM MANAGEMENT LLC 6.2%
Schonfeld Strategic Advisors LLC 6%
Parkman Healthcare Partners LLC 3.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Woodline Partners LP
13F
Company
13F
7.7%
$3,987,934
1,055,009 shares
 — 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
7.3%
$3,786,940
1,001,836 shares
 — 31 Mar 2024
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
6.2%
$3,230,377
854,597 shares
 — 31 Mar 2024
Schonfeld Strategic Advisors LLC
13F
Company
13F
6%
$3,124,548
826,600 shares
 — 31 Mar 2024
Parkman Healthcare Partners LLC
13F
Company
13F
3.7%
$1,904,568
503,854 shares
 — 31 Mar 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
1.8%
$917,281
242,667 shares
 — 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
30
Shares
6,849,687
Rows available
30
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
28
Q2 2024 holders
30
Holder diff
2
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .